Home Newsfeeds HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $25 Price Target

HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $25 Price Target

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $25 price target.

byBenzinga Newsdesk

February 17, 2023

1 minute read

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $25 price target.

News

‘Tesla Is Running Into Issues Building Battery Cells At Gigafactory Berlin’ – Electrek

By Benzinga Newsdesk

October 14, 11:12 AM

Tesla is running into issues building battery cells at Gigafactory Berlin | Electrek Tesla is reportedly running into problems establishing battery cell production at Gigafactory Berlin, and it is moving battery

TSLA

HC Wainwright & Co. Maintains Buy on Aptinyx, Lowers Price Target to $1

By Benzinga Newsdesk

August 26, 6:16 AM

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Aptinyx (NASDAQ:APTX) with a Buy and lowers the price target from $2 to $1.

APTX

SVB Leerink Downgrades Horizon Therapeutics to Market Perform, Raises Price Target to $116.5

By Benzinga Newsdesk

December 13, 7:08 AM

SVB Leerink analyst David Risinger downgrades Horizon Therapeutics (NASDAQ:HZNP) from Outperform to Market Perform and raises the price target from $88 to $116.5.

HZNP